FDA Adverse Event Injury Summary report: N

REFLEXION TOE SYSTEM

MDR report key: 1508378 · Received October 9, 2009

Report

Report Number
2027754-2009-00009
Event Type
Injury
Date Received
October 9, 2009
Date of Event
September 17, 2009
Report Date
October 9, 2009
Manufacturer
OSTEOMED L.P.
Product Code
LZJ
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NJ, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

PRODUCT IS NOT EXPECTED TO BE RETURNED TO COMPANY. THIS INFO IS BASED ON VERBAL INTERVIEW OF SURGEON.

Description of Event or Problem · 1

PT IMPLANTED IN 2008. APPROX 4 WEEKS POSTOP, PT SHOWED SIGNS OF WARMTH OR REDNESS AROUND IMPLANT SITE. NO COMPLAINTS MADE TO COMPANY AT THAT TIME. ON 9/9/2009, THE REP WAS INFORMED THAT THE PT WAS TO BE RE-OPERATED. THE PT HAD BEEN PUT ON IV ANTIBIOTICS IN INTERVENING PERIOD, ALTHOUGH, ALL BLOOD CULTURES AND BONE BIOPSIES WERE NEGATIVE FOR INFECTION. DOCTOR INDICATED HE BELIEVES PT HAD AN ALLERGIC REACTION TO IMPLANT BECAUSE SHE "HAD SENSITIVITY TO CERTAIN TYPES OF EARRINGS" GOING BACK SEVERAL YEARS. THE IFU CAUTIONS AGAINST USE OF THE PRODUCT IN PTS WITH KNOWN METAL SENSITIVITIES. NO SIMILAR COMPLAINTS HAVE BEEN RECEIVED IN THE LAST YEAR.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 REFLEXION TOE SYSTEM 1ST MPJ JOINT LZJ OSTEOMED L.P. 370-0423 1021716

Patients

Seq Age Sex Outcome Treatment
1 UNK Required Intervention AT THE TIME OF IMPLANT| THESE PRODUCTS ARE USED AS A SYSTEM| LOT# 370-0203| 370-0223, LOT #1021298